Impacts of Pretransplant Infections on Clinical Outcomes of Patients with Acute-On-Chronic Liver Failure Who Received Living-Donor Liver Transplantation
Authors:
Open Access
- 2 September 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (9) , e72893
Abstract
Liver transplantation is the only therapeutic modality for patients with acute-on chronic liver failure (ACLF). These patients are at high risk for bacterial infections while awaiting transplantation. The aim of this study was to elucidate whether an adequately treated bacterial infection influences the outcomes after transplantation in this patient population. 54 recipients (median age, 49.5 years [range, 22–60]) of adult-to-adult living donor liver transplant (LDLT) for ACLF were categorized as those with pretransplant infection (Group 1, n = 34) or without pretransplant infection (Group 2, n = 20) for retrospective analyses. With the exception of a higher male-female ratio (P = 0.046) and longer length of pretransplant hospital stay (P = 0.026) in Group 1, similar demographic, laboratory and clinical features were found in both groups. Patients in Group 1 (totally 42 pretransplant infection episodes) were adequately treated with effective antibiotic(s) before receiving LDLT. All included patients were followed up until one year after transplantation or death. Sixty-one posttransplant infection episodes were found in an overall of 44 ACLF patients (27 in Group 1 vs. 15 in Group 2; P = 0.352). Frequently encountered posttransplant infections were intraabdominal infection, pneumonia, bloodstream infection and urinary tract infection. Two patients died in each group (P = 0.622). No significant difference was found in the length of posttransplant ICU stay, and in one-year survival, graft rejection, and posttransplant infection rate between both groups. The longer overall hospital stay (mean day, 89.0 vs. 65.5, P = 0.024) found in Group 1 resulted from a longer pretransplant hospital stay receiving treatment for pretransplant infection(s) and/or awaiting transplantation. These data suggested that an adequately treated pretransplant infection do not pose a significant risk for clinical outcomes including posttransplant fatality in recipients in adult-to-adult LDLT for ACLF.Keywords
This publication has 32 references indexed in Scilit:
- Bacterial Bloodstream Infections in Liver Transplantation: Etiologic Agents and Antimicrobial Susceptibility ProfilesTransplantation Proceedings, 2012
- Agreement Assessment of Tigecycline Susceptibilities Determined by the Disk Diffusion and Broth Microdilution Methods among Commonly Encountered Resistant Bacterial Isolates: Results from the TigecyclineIn VitroSurveillance in Taiwan (TIST) Study, 2008 to 2010Antimicrobial Agents and Chemotherapy, 2012
- Immune Dysfunction and Infections in Patients With CirrhosisClinical Gastroenterology and Hepatology, 2011
- Rising problem of multidrug-resistant gram-negative bacteria causing bloodstream infections after liver transplantation: How should we handle the issue?Liver Transplantation, 2010
- Impact of pretransplant infections on clinical outcomes of liver transplant recipientsLiver Transplantation, 2010
- Liver transplantation for acute-on-chronic liver failureHepatology International, 2009
- Update in Infectious Diseases in Liver Transplant RecipientsClinics in Liver Disease, 2007
- The model for end-stage liver disease (MELD)Hepatology, 2007
- Clinical or epidemiologic diagnosis of nosocomial pneumoniaAmerican Journal of Infection Control, 2003
- OUTFLOW TRACT RECONSTRUCTION IN LIVING DONOR LIVER TRANSPLANTATION1Transplantation, 2000